Skip to main content
AAEM25 Main banner
Back
Evaluation

Scientific Assembly

Breve Dulce

Session: Breve Dulce III

What Happens After EPI/Dobutamine for My Failing Cardiogenic Shock Patient

Wednesday, April 9, 2025
11:15am – 11:25am ET
Location: Sandringham/Windsor - 2nd Level
CE: 0.25 CME Credit
Critical Care Recorded Session

    Speaker(s)

  • Elias E. Wan, FAAEM (he/him/his)

    Clinical Assistant Professor of Emergency Medicine at SUNY Downstate, Intensivist
    Maimonides Medical Center
    Jericho, New York

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Elias E. Wan, FAAEM: No financial relationships to disclose
You learn how to use the SCAI criteria and know your patient has cardiogenic shock. Ultrasound confirms and you start dobutamine or epinephrine and think all is well but the patient keeps looking worse. What is your next step, add more pressors or inotropes? Do they need a lasix drip? What about mechanical support? After this session, you will be equipped with an approach to choosing the right treatment for a patient with a delicate heart and know when and what treatment does benefit your cardiogenic shock patient.

Learning Objectives:

  • Review the SCAI categorization of cardiogenic shock and staging to help start treatment.
  • Describe when and how to choose different inotropes (Epinephrine vs Dobutamine vs Milrinone) and adjunct agents like diuretics, afterload reduction or pulmonary vasodilators.
  • Review non-traditional adjunctive therapies such as mechanical circulatory support i.e. ECMO, impella, RVAD and IABP, knowing when to pull the trigger and which one to choose.